Today on the Medscape Medical Minute: Researchers identify biomarkers linked to PTSD; Alzheimer's anti-amyloid drugs have the potential to compromise brain health; and the FDA reportedly plans to approve COVID boosters for those who are over 65 years old or immunocompromised.